Is it ethical to offer patients cash to boost hep C treatment?

A new approach is needed if Australia is to stamp out hepatitis C in the next decade, says Professor Mark Stoové

Financial incentives should be used to boost hepatitis C testing rates among difficult to reach patient groups, including people who inject drugs, a leading public health researcher says.

Professor Mark Stoove
Professor Mark Stoove.

Professor Mark Stoové, head of public health at the Burnet Institute in Melbourne, says “innovative” approaches are needed to boost testing rates and treatment uptake.